Pharmaceutical Business review

Blue Marble Energy Enters Into Partnership With Bionavitas

Blue Marble Energy and Bionavitas have entered into a partnership in which Blue Marble Energy will produce biochemicals from microalgae supplied by Bionavitas.

Based in Redmond, Washington, Bionavitas has developed Light Immersion Technology that enables the rapid, cost-effective production of algae for environmental remediation, manufacturing health and nutraceutical products, and producing biofuels.

Light Immersion Technology can be used to grow algae to remediate selenium, zinc, lead, cadmium, boron, mercury, and other undesirable elements and compounds from industrial waste streams. Blue Marble can then safely process the generated algae biomass into specialty biochemicals.

Kelly Ogilvie, CEO of Blue Marble, said: “There is no question that algae are a key component of the solution and will help reduce our dependence on fossil fuels. But fuel isn’t the only useful product that can be developed using algae. While many people think of oil simply as a source of fuel, it is also an important component of almost everything we eat, drink, manufacture, and wear. With the efficient algae-production capability of Bionavitas, and our ability to convert that algae into specialty biochemicals, it was a natural step for our companies to partner.”

Michael Weaver, CEO of Bionavitas, said: “Our Light Immersion Technology gives us the ability to efficiently produce high quality algae that is uniquely suited for Blue Marble’s processing technology. We look forward to jointly pursuing commercialization opportunities for our combined technologies.”

Seattle based, Blue Marble Energy has developed a technology to produce a wide array of high-margin, carbon neutral specialty biochemicals from organic biomass. These biochemicals include esters, a group of chemicals used in food, fragrance, plastics, resins and adhesives.